IP Library › Assignment 072107/0559
Patent Assignment
Reel/Frame 072107/0559

Change of Name

Recorded: 2025-08-25 Pages: 3
Assignor
ALETHIA BIOTHERAPEUTICS INC.
Executed: 2023-11-30
Assignee
ALETHIA BIOTHERAPEUTICS ULC
141 PRESIDENT KENNEDY AVENUE, SUITE SB-5100, MONTREAL, H2X 1Y4, CANADA
Covered Properties (3)
Anti-Clusterin Antibodies and Antigen Binding Fragments and Their Use to Reduce Tumor Volume
Patent: 8,802,826 →
Application: 13/502,427 →
Publication: US 2012/0282251
Anti-Clusterin Antibodies and Antigen Binding Fragments and Their Use to Reduce Tumor Volume
Patent: 9,512,211 →
Application: 14/311,840 →
Publication: US 2014/0302020
Co-Use of a Clusterin Inhibitor with an Egfr Inhibitor to Treat Cancer
Patent: 9,822,170 →
Application: 14/374,967 →
Publication: US 2015/0044220
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 9, 2012
From: TREMBLAY, GILLES BERNARD; FILION, MARIO; SULEA, TRAIAN
To: ALETHIA BIOTHERAPEUTICS INC.; NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 029268/0547 →
Deed of Hypothec on Specific Universalities of Movable Property Jan 10, 2014
From: ALETHIA BIOTHERAPEUTICS INC./ALETHIA BIOTHERAPEUTIQUES INC.
To: IBC GENERIUM LLC
Reel/Frame 031968/0937 →
Assignment of Assignor's Interest Oct 8, 2014
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 033914/0059 →
Assignment of Assignor's Interest Oct 8, 2014
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 033914/0137 →
License Mar 25, 2015
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 035251/0608 →
Assignment of Assignor's Interest Mar 25, 2015
From: TREMBLAY, GILLES BERNARD; VIAU, ELISABETH; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 035252/0392 →
Release of Security Interest Nov 20, 2023
From: JOINT-STOCK COMPANY GENERIUM
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 065622/0749 →